Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration.

Saved in:
Bibliographic Details
Title: Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration.
Authors: Kočvarová, Radka1 (AUTHOR), Azar, Shahar1 (AUTHOR), Agranovich, Bella2 (AUTHOR), Abramovich, Ifat2 (AUTHOR), Kirillov, Saveliy3 (AUTHOR), Nemirovski, Alina1 (AUTHOR), Baraghithy, Saja1 (AUTHOR), Plaschkes, Inbar4 (AUTHOR), Merquiol, Emmanuelle5 (AUTHOR), Rouvinski, Alexander3 (AUTHOR), Blum, Galia5 (AUTHOR), Hinden, Liad1 (AUTHOR) liad.hinden@mail.huji.ac.il, Tam, Joseph1 (AUTHOR) yossi.tam@mail.huji.ac.il
Source: British Journal of Pharmacology. Jun2026, Vol. 183 Issue 12, p3173-3194. 22p.
Database: Academic Search Ultimate
Description
ISSN:00071188
DOI:10.1111/bph.70387